| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
5e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.21 |
5e-05 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |